Serological microarray for detection of HSV-1, HSV-2, VZV, and CMV antibodies

Journal of Virological Methods

Volumn 160, Issue 1-2, 2009, Pages 167-171

  Jääskeläinen, Anne J ^a,b   Moilanen, Kirsi ^a   Bühler, Suvi ^b   Lappalainen, Maija ^b   Vapalahti, Olli ^a,b   Vaheri, Antti ^a,b   Piiparinen, Heli ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Antigen; Diagnosis; Herpesvirus; Microarray; Serology

Indexed keywords

GLYCOPROTEIN E; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; NUCLEOCAPSID PROTEIN; PHOSPHOPROTEIN; PHOSPHOPROTEIN PP150; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; ENZYME IMMUNOASSAY; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; IMMUNOFLUORESCENCE; INTERMETHOD COMPARISON; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PUUMALA VIRUS; SENSITIVITY AND SPECIFICITY; SEROLOGY; STANDARDIZATION; VARICELLA ZOSTER VIRUS; VIRUS DETECTION;

ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CYTOMEGALOVIRUS; HANTAVIRUS; HANTAVIRUS INFECTIONS; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PROTEIN ARRAY ANALYSIS; SENSITIVITY AND SPECIFICITY; VARICELLOVIRUS;

CYTOMEGALOVIRUS; HERPESVIRIDAE; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; HUMAN HERPESVIRUS 3; PUUMALA VIRUS; SIMPLEXVIRUS;

EID: 67549114814     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2009.05.013     Document Type: Article

References (39)

1. Aarnisalo J., Ilonen J., Vainionpää R., Volanen I., Kaitosaari T., and Simell O. Development of antibodies against cytomegalovirus, varicella-zoster virus and herpes simplex virus in Finland during the first eight years of life: a prospective study. Scand. J. Inf. Dis. 35 (2003) 750-753
2. Arvaja M., Lehtinen M., Koskela P., Lappalainen M., Paavonen J., and Vesikari T. Serological evaluation of herpes simplex virus type 1 and type 2 infections in pregnancy. Sex. Transm. Infect. 75 (1999) 168-171
3. Ashley R.L. Performance and use of HSV type-specific serology test kits. Herpes 9 (2002) 38-45
4. Ashley R.L., Wu L., Pickering J.W., Tu M.C., and Schnorenberg L. Premarket evaluation of a commercial glycoprotein G-based enzyme immunoassay for herpes simplex virus type-specific antibodies. J. Clin. Microbiol. 36 (1998) 294-295
5. Ashley-Morrow R., Krantz E., and Wald A. Time course of seroconversion by HerpeSelect ELISA after acquisition of genital herpes simplex virus type 1 (HSV-1) or HSV-2. Sex. Transm. Dis. 30 (2003) 310-314
6. Boriskin Y.S., Rice P.S., Stabler R.A., Hinds J., Al-Ghusein H., Vass K., and Butcher P.D. DNA microarrays for virus detection in cases of central nervous system infection. J. Clin. Microbiol. 42 (2004) 5811-5818
7. Brown Z.A., Benedetti J., Ashley R., Burchett S., Selke S., Berry S., Vontver L.A., and Corey L. Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N. Engl. J. Med. 324 (1991) 1247-1252
8. Brown Z.A., Selke S., Zeh J., Kopelman J., Maslow A., Ashley R.L., Watts D.H., Berry S., Herd M., and Corey L. The acquisition of herpes simplex virus during pregnancy. N. Engl. J. Med. 337 (1997) 509-515
9. Burgess S.T., Kenyon F., O'Looney N., Ross A.J., Kwan M.C., Beattie J.S., Petrik J., Ghazal P., and Campbell C.J. A multiplexed protein microarray for the simultaneous serodiagnosis of human immunodeficiency virus/hepatitis C virus infection and typing of whole blood. Anal. Biochem. 382 (2008) 9-15
10. Frenkel L.M., Garratty E.M., Shen J.P., Wheeler N., Clark O., and Bryson Y.J. Clinical reactivation of herpes simplex virus type 2 infection in seropositive pregnant women with no history of genital herpes. Ann. Intern. Med. 118 (1993) 414-418
11. Grosse S.D., Ross D.S., and Dollard S.C. Congenital cytomegalovirus (CMV) infection as a cause of permanent bilateral hearing loss: A quantitative assessment. J. Clin. Virol. 41 (2008) 57-62
12. Hanson K.E., Alexander B.D., Woods C., Petti C., and Reller L.B. Validation of laboratory screening criteria for herpes simplex virus testing of cerebrospinal fluid. J. Clin. Microbiol. 45 (2007) 721-724
13. Hasan U.A., Harper D.R., Wren B.W., and Morrow W.J. Immunization with a DNA vaccine expressing a truncated form of varicella zoster virus glycoprotein E. Vaccine 20 (2002) 1308-1315
14. Jääskeläinen A.J., and Maunula L. Applicability of microarray technique for the detection of noro- and astroviruses. J. Virol. Methods 136 (2006) 210-216
15. Jääskeläinen A.J., Piiparinen H., Lappalainen M., Koskiniemi M., and Vaheri A. Multiplex-PCR and oligonucleotide microarray for detection of eight different herpesviruses from clinical specimens. J. Clin. Virol. 37 (2006) 83-90
16. Jääskeläinen A.J., Piiparinen H., Lappalainen M., and Vaheri A. Improved multiplex-PCR and microarray for herpesvirus detection from CSF. J. Clin. Virol. 42 (2008) 172-175
17. Kallio-Kokko H., Leveelahti R., Brummer-Korvenkontio M., Lundkvist A., Vaheri A., and Vapalahti O. Human immune response to Puumala virus glycoproteins and nucleocapsid protein expressed in mammalian cells. J. Med. Virol. 65 (2001) 605-613
18. Kallio-Kokko H., Vapalahti O., Lundkvist A., and Vaheri A. Evaluation of Puumala virus IgG and IgM enzyme immunoassays based on recombinant baculovirus-expressed nucleocapsid protein for early nephropathia epidemica diagnosis. Clin. Diagn. Virol. 10 (1998) 83-90
19. Klaassen C.H., Prinsen C.F., de Valk H.A., Horrevorts A.M., Jeunink M.A., and Thunnissen F.B. DNA microarray format for detection and subtyping of human papillomavirus. J. Clin. Microbiol. 42 (2004) 2152-2160
20. La Rosa C., Wang Z., Lacey S.F., Markel S.F., Sharma M.C., Martinez J., Lalimarmo M.M., and Diamond D.J. Characterization of host immunity to cytomegalovirus pp150 (UL32). Hum. Immunol. 66 (2005) 116-126
21. Landini M.P., Ripalti A., Sra K., and Pouletty P. Human cytomegalovirus structural proteins: immune reaction against pp150 synthetic peptides. J. Clin. Microbiol. 29 (1991) 1868-1872
22. Langenberg A., Benedetti J., Jenkins J., Ashley R., Winter C., and Corey L. Development of clinically recognizable genital lesions among women previously identified as having asymptomatic herpes simplex virus type 2 infection. Ann. Intern. Med. 110 (1989) 882-887
23. Lovmar L., Fock C., Espinoza F., Bucardo F., Syvänen A.C., and Bondeson K. Microarrays for genotyping human group a rotavirus by multiplex capture and type-specific primer extension. J. Clin. Microbiol. 41 (2003) 5153-5158
24. Lu D.D., Chen S.H., Zhang S.M., Zhang M.L., Zhang W., Bo X.C., and Wang S.Q. Screening of specific antigens for SARS clinical diagnosis using a protein microarray. The Analyst 130 (2005) 474-482
25. McKendrick M.W., Lau J., Alston S., and Bremner J. VZV infection in pregnancy: a retrospective review over 5 years in Sheffield and discussion on the potential utilisation of varicella vaccine in prevention. J. Infect. 55 (2007) 64-67
26. Mezzasoma L., Bacarese-Hamilton T., Di Cristina M., Rossi R., Bistoni F., and Crisanti A. Antigen microarrays for serodiagnosis of infectious diseases. Clin. Chem. 48 (2002) 121-130
27. Morris M.C., Edmunds W.J., Hesketh L.M., Vyse A.J., Miller E., Morgan-Capner P., and Brown D.W. Sero-epidemiological patterns of Epstein-Barr and herpes simplex (HSV-1 and HSV-2) viruses in England and Wales. J. Med. Virol. 67 (2002) 522-527
28. Nardone A., de Ory F., Carton M., Cohen D., van Damme P., Davidkin I., Rota M.C., de Melker H., Mossong J., Slacikova M., Tischer A., Andrews N., Berbers G., Gabutti G., Gay N., Jones L., Jokinen S., Kafatos G., de Aragon M.V., Schneider F., Smetana Z., Vargova B., Vranckx R., and Miller E. The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region. Vaccine 25 (2007) 7866-7872
29. Norberg P., Kasubi M.J., Haarr L., Bergstrom T., and Liljeqvist J.A. Divergence and recombination of clinical herpes simplex virus type 2 isolates. J. Virol. 81 (2007) 13158-13167
30. Oladepo D.K., Klapper P.E., Percival D., and Vallely P.J. Serological diagnosis of varicella-zoster virus in sera with antibody-capture enzyme-linked immunosorbent assay of IgM. J. Virol. Methods 84 (2000) 169-173
31. Pebody R.G., Andrews N., Brown D., Gopal R., De Melker H., Francois G., Gatcheva N., Hellenbrand W., Jokinen S., Klavs I., Kojouharova M., Kortbeek T., Kriz B., Prosenc K., Roubalova K., Teocharov P., Thierfelder W., Valle M., Van Damme P., and Vranckx R. The seroepidemiology of herpes simplex virus type 1 and 2 in Europe. Sex. Transm. Infect. 80 (2004) 185-191
32. Perkins D., Chong H., Irvine B., and Domagalski J. Genital co-infection with herpes simplex viruses type 1 and 2: comparison of real-time PCR assay and traditional viral isolation methods. J. Cell. Mol. Med. 11 (2007) 581-584
33. Sauerbrei A., and Wutzler P. Serological detection of type-specific IgG to herpes simplex virus by novel ELISAs based on recombinant and highly purified glycoprotein G. Clin. Lab. 50 (2004) 425-429
34. Svahn A., Berggren J., Parke A., Storsaeter J., Thorstensson R., and Linde A. Changes in seroprevalence to four herpesviruses over 30 years in Swedish children aged 9-12 years. J. Clin. Virol. 37 (2006) 118-123
35. Vapalahti O., Lundkvist A., Kallio-Kokko H., Paukku K., Julkunen I., Lankinen H., and Vaheri A. Antigenic properties and diagnostic potential of Puumala virus nucleocapsid protein expressed in insect cells. J. Clin. Microbiol. 34 (1996) 119-125
36. Wald A., and Ashley-Morrow R. Serological testing for herpes simplex virus (HSV)-1 and HSV-2 infection. Clin. Infect. Dis. 35 (2002) S173-S182
37. Wang D., Coscoy L., Zylberberg M., Avila P.C., Boushey H.A., Ganem D., and DeRisi J.L. Microarray-based detection and genotyping of viral pathogens. Proc. Natl. Acad. Sci. U.S.A 99 (2002) 15687-15692
38. Wutzler P., Farber I., Wagenpfeil S., Bisanz H., and Tischer A. Seroprevalence of varicella-zoster virus in the German population. Vaccine 20 (2001) 121-124
39. Zhu H., Hu S., Jona G., Zhu X., Kreiswirth N., Willey B.M., Mazzulli T., Liu G., Song Q., Chen P., Cameron M., Tyler A., Wang J., Wen J., Chen W., Compton S., and Snyder M. Severe acute respiratory syndrome diagnostics using a coronavirus protein microarray. Proc. Natl. Acad. Sci. U.S.A 103 (2006) 4011-4016